Jinyu Bio-technology Co., Ltd. (SHA:600201)
14.95
+0.41 (2.82%)
Mar 6, 2026, 3:00 PM CST
Jinyu Bio-technology Market Cap
Jinyu Bio-technology has a market cap or net worth of 16.34 billion as of March 6, 2026. Its market cap has increased by 121.25% in one year.
Market Cap
16.34B
Enterprise Value
15.15B
Revenue
1.33B
Ranking
n/a
PE Ratio
155.60
Stock Price
14.95
Market Cap Chart
Since January 18, 1999, Jinyu Bio-technology's market cap has increased from 977.52M to 16.34B, an increase of 1,571.21%. That is a compound annual growth rate of 10.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 16.34B | -0.80% |
| Dec 31, 2025 | 16.47B | 114.89% |
| Dec 31, 2024 | 7.66B | -34.56% |
| Dec 29, 2023 | 11.71B | 18.94% |
| Dec 30, 2022 | 9.85B | -46.16% |
| Dec 31, 2021 | 18.29B | -22.27% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Suzhou Zelgen Biopharmaceuticals | 20.57B |
| BrightGene Bio-Medical Technology | 17.02B |
| Sinocelltech Group | 16.52B |
| Anhui Anke Biotechnology (Group) | 15.70B |
| Inner Mongolia Furui Medical Science | 14.76B |
| Tibet Cheezheng Tibetan Medicine | 14.21B |
| Pacific Shuanglin Bio-pharmacy | 13.20B |
| Vcanbio Cell & Gene Engineering Corp., | 12.81B |